[24] Halstead S.B. and Aguiar, M. (2016). Is discussion of dengue vaccination for the 2016 Olympics necessary? The Lancet, 388(10054): 1881–1882.

[23] Aguiar, M., Stollenwerk, N. and Halstead S.B. (2016). The risks behind Dengvaxia recommendation. The Lancet Infectious Diseases, 16(8): 882-883.

[22] Halstead S.B. and Aguiar, M. (2016). Dengue vaccine and the 2016 Olympics. The Lancet 38(10041): 237-238.

[21] Halstead, S.B. and Aguiar, M. (2016). Dengue Vaccines: are they safe for Travelers? Travel Medicine and Infectious Disease, 14(4): 378-383.

[20] Mateus, L., Masoero, D., Rocha, F., Aguiar, M., Skwara, U., Ghaffari, P., Zambrini, Jean-Claude and Stollenwerk, N. (2016). Epidemiological models in semiclassical approximation: an analytically solvable model as a test case. Mathematical Methods in Applied Sciences, 39(16): 4914-4922.

[19] F. Rocha, Mateus, L., U. Skwara, M. Aguiar and N. Stollenwerk. (2016). Understanding dengue fever dynamics: a study of seasonality in vector borne disease models. International Journal of Computer Mathematics, 93(8): 1405-1422.

[18] Mateus, L., Ghaffari, P., Skwara, U., Rocha, F., Aguiar, M., Masoero, D. and Stollenwerk, N. (2015). Semiclassical approximations of stochastic epidemiological processes towards parameter estimation using as prime example the SIS system with import. Ecological Complexity, 27: 63-73.

[17] Aguiar, M., Coelho, G.E., Mateus, L., Rocha, R., Pessanha, J.E.M., Mateus, L. and Stollenwerk, N. (2015). Dengue transmission during the 2014 FIFA World Cup in Brazil. The Lancet Infectious Diseases, 15(7): 765-766.